ReviewPharmacoEconomics2005

The cost effectiveness of orlistat in a 1-year weight-management programme for treating overweight and obese patients in Sweden : a treatment responder approach.

Peter HertzmanPubMed ↗Publisher ↗

No numbers read from the abstract.